Form 4: ABEONA THERAPEUTICS Director Sells Shares to Cover Tax Obligations

ABEONA THERAPEUTICS Director Christine Berni Silverstein sold 13,093 shares of common stock at a weighted average price of $5.8557 to cover tax obligations from restricted stock award vesting.

Summary

• Christine Berni Silverstein, a Director of ABEONA THERAPEUTICS INC. (ABEO), sold 13,093 shares of common stock.
• The transaction occurred on July 9, 2025.
• The shares were sold at a weighted average price of $5.8557, with individual sales ranging from $5.78 to $5.92.
• The purpose of the sale was to cover tax obligations related to the vesting of restricted stock awards.
• Following this transaction, Christine Berni Silverstein beneficially owns 120,479 shares of ABEONA THERAPEUTICS common stock.

Sentiment

Score: 6

Explanation: The sale of shares by a director is for tax obligations related to restricted stock vesting, which is a common and generally neutral event, not indicating a negative outlook on the company.

Positives

• The sale was explicitly stated to cover tax obligations associated with the vesting of restricted stock awards, indicating a non-discretionary sale rather than a lack of confidence in the company.

Negatives

• A director selling shares, even for tax purposes, reduces their direct ownership in the company.

Future Outlook

This Form 4 does not contain forward-looking statements or guidance. It reports a past transaction.

Management Comments

• The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive.

Industry Context

This Form 4 reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The reported transaction is a sale of common stock by a director, which is a related party transaction.

Stakeholder Impact

• Shareholders: The sale by a director slightly reduces insider ownership, but the stated reason (tax obligations) mitigates concerns about management confidence.

Key Dates

Recommendation

Keywords

ABEONA THERAPEUTICS, ABEO, Form 4, insider trading, stock sale, director, Christine Berni Silverstein, restricted stock, tax obligations, beneficial ownership